Malaria is a parasitic disease that causes severe hemolytic anemia in Plasmodium-infected hosts, which results in the release and accumulation of oxidized heme (hemin). Although hemin impairs the establishment of Plasmodium immunity in vitro and in vivo, mice preconditioned with hemin develop lower parasitemia when challenged with Plasmodium chabaudi adami blood stage parasites. In order to understand the mechanism accounting for this resistance as well as the impact of hemin on eryptosis and plasma levels of scavenging hemopexin, red blood cells were labeled with biotin prior to hemin treatment and P. c. adami infection. This strategy allowed discriminating hemin-treated from de novo generated red blood cells and to follow the infection within these two populations of cells. Fluorescence microscopy analysis of biotinylated-red blood cells revealed increased P. c. adami red blood cells selectivity and a decreased permissibility of hemin-conditioned red blood cells for parasite invasion. These effects were also apparent in in vitro P. falciparum cultures using hemin-preconditioned human red blood cells. Interestingly, hemin did not alter the turnover of red blood cells nor their replenishment during in vivo infection. Our results assign a function for hemin as a protective agent against high parasitemia, and suggest that the hemolytic nature of blood stage human malaria may be beneficial for the infected host.
Introduction
Malaria is a mosquito-borne infectious disease with a human etiology dating back to the divergence between great apes and humans, approximately 5 million years ago [1, 2] . This long period of interactions allowed both Plasmodium and humans to co-evolve in order to reach a trade-off state in which less than 1% of infected patients die [3] . However, considering the high number of afflicted individuals (>200 000 000 per year), malaria remains one of the most deadly infectious disease of our era.
Plasmodium requires the interaction with 2 cell types within the human body for completion of the complex life cycle, and the pathogenesis of malaria takes place during the asexual solution (0.9%) and was injected intravenously (iv) into each mouse. Mice were then injected by the intraperitoneal (ip) route with 10 mg/kg of freshly prepared HE (porcine; SigmaAldrich, Canada) or saline (control) for 3 consecutive days. For this, a 25 mg/mL (38.3 mM) stock HE solution was prepared in 0.1 M NaOH, and further dissolved in saline solution. Following treatment, control and HE-treated mice were infected with 5x10 5 P. c. adami DK-parasitized RBCs from a syngeneic donor mouse, by the ip route. Parasitemia was estimated daily on 500 RBCs from tail tip blood smears fixed in 100% methanol and stained with 0.4% Giemsa (Sigma-Aldrich).
Hematological analysis
Daily Hgb concentrations were determined by collecting 2 μL of tail tip blood in 498 μL of Drabkin's solution (Sigma-Aldrich). Absorbance was measured in duplicate (540 nm) with a microplate reader (BioTek; Eon spectrophotometer), and a standard curve was performed with rat Hgb (Sigma-Aldrich) to convert the values into g/dL. To assess the percentage of reticulocytes and biotinylated RBCs, whole blood cells were stained with FITC-labeled rat anti-mouse CD71 monoclonal antibody (BioLegend, Canada, clone R17217) and APC-labeled streptavidin (strep) (BioLegend) in PBS (HyClone, Thermo Scientific; w/o Mg 2+ and Ca 2+ ), and incubated for 30 min in the dark at 4°C. Cells were washed once before fluorescence-activated cell sorting (FACS) analysis. RBCs turnover before infection was established as the percentage of biotinylated RBCs, which was multiplied by the number of RBCs in blood and presented as a concentration (10 9 RBCs/mL) for post-infection turnover. Cell counting was assessed in 1 μL of blood diluted in 1 mL of PBS, and carried out with the flow cytometer previously calibrated with a reference count bead.
Plasma hemopexin quantification
Hemopexin quantification was performed by ELISA commercial kit (Kamiya Biomedical, USA, cat no. KT-345) according to the manudacturer's specifications (dilution 1/20 000).
Oxidative status and RBCs ageing analysis
Altered membrane phospholipid asymmetry and RBC ageing was evaluated with Annexin-V (Life Technologies, Canada) and anti-CD47 (BioLegend, clone miap301) staining. Briefly, 1 μL of blood was collected in 1 mL of PBS, and centrifuged. Pellet was resuspended in Annexin binding buffer (Life Technologies), stained with FITC-labeled Annexin-V, PE-labeled rat antimouse CD47 monoclonal antibody and streptavidin-APC, and incubated at 20°C, in the dark for 15 min. Cells were washed and resuspended in PBS prior to FACS analysis of geometric mean of fluorescence intensity (gmeanFI) relative to Annexin-V and CD47 in streptavidin positive cells. Intra-erythrocytic ROS were measured using a modification of the Amer method [25] . Briefly, 2 x 10 6 RBCs/mL were incubated at 37°C for 15 min in the dark with streptavidin-APC and 2',7'-dichlorofluorescein diacetate (DCFDA; Sigma-Aldrich) dissolved in methanol. Cells were washed in PBS and analyzed for gmeanFI of 2',7'-dichlorofluorescein (DCF) within streptavidin positive cells. Positive controls for Annexin-V and CD47 binding, and ROS measurement were achieved with a 15 min cells treatment with 50 μM hydrogen peroxide prior to washing and labeling.
logarithmic mode, and 40, 000 intact cells were acquired for each sample. Positive fluorescence was defined by a comparison with unstained control samples, except for streptavidin positive cells, which were compared to stained un-biotinylated cells.
Evaluation of Plasmodium chabaudi adami blood stage with DAPI staining and DIC microscopy
To study late schizogony (merozoites formation), parasites invasion (extra-erythrocytic merozoites) and ring-stages during infection, blood smears were performed on glass coverslips #1.5 (Fisherbrand), at day 6 and 7 post-infection. Blood slides were fixed in 100% methanol and stained with 1 μg/mL 4',6-diamidino-2-phenylindole (DAPI) dihydrochloride (Sigma-Aldrich) in the dark for 30 min. Coverslips were washed in PBS, allowed to dry and mounted on microscope slides with 30% glycerol in PBS. Cells were imaged by differential interference contrast (DIC) and fluorescence microscopy (Nikon A1 confocal, plan Apochromat VC 60x, numerical aperture 1.4, λs oil immersion) and analyzed with NIS-Elements Viewer 4.20 imaging software (Nikon).
Assessment of parasites RBCs selectivity
DAPI stained smears of ring-stage P. c. adami infection and Giemsa stained smears of P. falciparum were analyzed for RBCs containing more that 1 ring-shape parasite in >150 iRBCs. The selectivity index (SI) was calculated as described by Simpson and others [26] , and was defined as the ratio of the observed number of multiple invaded RBCs to that expected from an unrestricted random invasion process (Poisson distribution).
Confocal microscopy quantification of infection Plasmodium falciparum culture and treatment P. falciparum strain Dd2 was cultured continuously using a protocol modified from Trager and Jensen [27] . In~5% hematocrit, parasites were held in RPMI medium (Life Technologies, USA) supplemented with gentamicin (20μg/mL) (Life Technologies), hypoxanthine (0.1mM) (BioShop, Canada) and 0.5% AlbuMAX (Life Technologies), and maintained at 37°C, 5% CO 2 , 3% O 2 and 92% N 2 . Erythrocytes (A + blood type) were obtained from Interstate Blood Bank (USA). Parasites growth was monitored daily using Giemsa stained thin blood smears, and parasitemia was adjusted when required. Synchrony at ring stage was achieved by incubating parasites with 5% D-sorbitol (Bioshop) at 37°C for 10 min before resuspending parasites in culture medium. For HE pre-treatment experiments, uninfected RBCs (3.33% in culture medium) were incubated with 50 μM HE for 18 h at 37°C in a water bath. After removal of HE containing medium, parasites were cultured in triplicate with~3.33% hematocrit using regular culturing conditions (37°C, 5% CO2, 3% O2, and 92% N2), with a starting parasitemia of 0.25%. Media was changed and thin blood smears for parasite counting were prepared daily. Parasitemia and blood stages were recorded based on blood smear quantification.
Results

HE administration does not promote premature ageing or removal of RBCS in vivo
We previously reported decreased parasitemia in mice conditioned with HE prior to infection with P. c. adami DK parasites [23] . In an endeavor to study the effect of HE-preconditioning on RBCs subjected to Plasmodium infection, HE-treated RBCs were distinguished from RBCs differentiated post-treatment by sulfo-NHS-LC-biotin labelling in vivo, prior to HE injections, resulting in 98.1±0.9% labeled RBCs. Flow cytometry analysis included streptavidin staining to allow an exclusive comparison between cells in circulation during HE or saline treatment (strep + cells), respectively in HE-conditioned and control mice. In the present investigation, the reported decreased peak and cumulative P. c. adami parasitemia in HE-preconditioned mice were reproduced, and an earlier recovery from the infection was also observed (Fig 1A-1C) . Plasmodium invasion and growth imposes stress on host RBCs [28, 29] , and the possibility that HE-treated RBCs are removed from circulation prior to completion of parasite differentiation was addressed. To explore a plausible involvement of host RBC senescence and eryptosis in decreased parasitemia, the status of RBCs was evaluated 3 h after the last HE/saline injection, as well as 7 days post-infection. Hallmarks of eryptosis are cell shrinkage and membrane phospholipid scrambling, and enhanced intra-erytrocytic ROS activity and loss in expression of the CD47 membrane protein are features of oxidative stress and ageing in RBCs [17, 30, 31] . Cell volume was evaluated from forward scatter (FSC) FACS analysis and phosphatidylserine exposure at the surface of RBCs was estimated as the gmeanFI relative to Annexin-V binding. FACS analysis of control and HE-treated RBCs failed in disclosing any differences, suggesting that pre-treatment with HE does not decrease RBC volume or increase translocation of phosphatidylserine to the outer leaflet of RBC membranes ( Fig 1D and 1E and 1H-1I). Similarly, assessment of intra-erythrocytic ROS activity and RBCs premature ageing, evaluated with the DCFDA and anti-CD47 antibody gmeanFI respectively, did not reveal major differences between control and HE-preconditioned RBCs, after HE treatment or during infection (Fig 1F,  1G , 1J and 1K). As oxidized or senescent RBCs are rapidly removed from circulation by phagocytes in vivo, RBC turnover was evaluated by combining the biotin labeling with flow cytometry blood cell counts. This strategy enabled in vivo estimation of the concentrations of new (strep -) and old (strep + ) RBCs in the circulatory system. No significant differences were found in the concentrations of de novo generated and residual RBCs after HE treatment, or during the course of the infection (Fig 2A and 2B) . However, as reported previously [23] , lower concentrations of Hgb were measured in HE-preconditioned mice with respect to control mice prior to peak infection (Fig 2C) . Concomitant with the faster parasitemia recovery in HE-preconditioned mice, the onset of reticulocytosis started earlier in these mice but, displayed an overall identical kinetic-curve as in control mice (Fig 2D) . These results suggest that despite decreased parasitemia and lower Hgb levels in HE-preconditioned mice, HE does not result in an accelerated ageing and/or turnover of RBCs, prior to and post-infection.
Plasmodium chabaudi adami schizogony is not altered, but merozoite invasion is delayed, in HE-treated RBCs
Our data indicated reduced parasitemia in HE-conditioned mice without major changes in RBC turnover or premature ageing. Decreased parasitic replication concurrent with a reduced number of merozoites per schizogony cycle could account for the differences in parasitemia found in HEconditioned mice. To evaluate a possible drop in merozoite numbers in HE-conditioned RBCs, a combination of fluorescence microscopy and differential interference contrast (Nomarski) Fig 1. Markers of oxidative stress and ageing in RBCs from HE-preconditioned mice infected with Plasmodium chabaudi adami. BALB/c mice received intravenous injection of sulfo-NHS-LC-biotin (1 mg/100μl/mouse) to label RBCs in circulation, one day prior to a first HE treatment. Saline (control) or HE (10 mg/kg/day) were administered by the intraperitoneal (ip) route for 3 days and followed by ip injection of 5x10 5 P. c. adami iRBCs, on the 4 th day. Tail-tip blood smears stained with Giemsa were performed daily to follow the parasitemia (A), determine the magnitude of peak parasitemia (B) and estimate cumulative parasitemia (calculated as the sum of daily parasitemia) (C). Three hours after the 3 rd and last saline/HE injection, the mean volume of RBCs was estimated from FSC values (D), and gmeanFI relative to Annexin-V binding (E), DCFDA labeling (F) and CD47 expression (G) were estimated by flow cytometry on 40 000 RBCs positive for streptavidin. These parameters were also analysed 7 days after P. c. adami infection (H-K). Data in A-C are the means ± SEM of three independent experiments (n = 11), and data in D-K are the means ± SEM of one experiment (Ctrl; n = 4, HE; n = 3). An unpaired Student t test was performed to compare the control group to the HE-treated one, *p<0.05, **p<0.01, *** p<0.001.
imaging was adopted (S1 Fig). At the time of peak parasitemia, intra-erythrocytic merozoites were visualized within schizont-iRBCs as DAPI positive nuclei. The proportion of mature-schizont-iRBCs containing 4 or more merozoites did not differ between HE-treated and control mice (Fig 3A) . However, DAPI-stained blood smears obtained from mice once the merozoite invasion cycle was accomplished (day 6 post-infection, 16 o'clock in a reverse light cycle) revealed higher numbers of extra-erythrocytic parasites in HE-preconditioned mice (Fig 3B and 3C) . These data suggest that HE delays merozoite invasion of RBCs but does not affect schyzogony.
The number of RBCs permissible to Plasmodium chabaudi adami invasion decreases in HE-conditioned mice
The severity of Plasmodium infections varies with the parasite strain and host RBC polymorphisms. Severe malaria and high parasitemia have been associated with unrestricted RBC invasion by the parasites [26, [32] [33] [34] . In contrast, uncomplicated malaria seems more related to selective RBC invasion e.g., P. vivax parasite's preference for reticulocytes which results in lower ( 2%) parasite burden [26] . Our data revealed decreased parasitemia and limited invading capacity of merozoites in HE-preconditioned mice, suggesting that a more restricted RBC population is permissive to P. c. adami invasion and that merozoites may take more time to find suitable RBC to invade. From the analysis of DAPI-stained blood smears, the parasite selectivity index (SI) was estimated to establish a correlation between lower parasitemia and plausible more restricted RBC selection in HE-treated cells. This index was calculated by dividing the observed proportion of multiple-ring-iRBCs in control and HE-treated mice by the expected number of multiple-ring-iRBCs estimated from an unrestricted, or random, invasion process (Poisson distribution) [26] . The SI, at both 6 and 7 days post-infection, confirmed the data provided by fluorescence microscopy of DAPI-stained parasites rings-iRBCs, revealing a higher percentage of multiple-iRBCs in HE-preconditioned mice and more than 2 fold increase in P. c. adami RBCs selectivity (Fig 4) .
HE conditioned-RBCs impede Plasmodium invasion
Considering the parasite SI estimated from HE-treated RBCs, the possibility that HE may directly influence the selectivity of RBCs by Plasmodium was evaluated. Using sulfo-NHS-LCbiotin labelling combined with streptavidin, DNA (DAPI) and reticulocytes (anti-CD71 antibody) staining, iRBCs conditioned by HE were distinguished from those generated thereafter. Confocal microscopy analysis revealed that the decreased parasitemia detected in HE-treated mice only occurred within the strep + population when compared to control mice (Fig 5A) . No major differences were found with respect to infection of new RBCs (strep -) between the two groups of mice. This observation suggests that the decreased parasitemia in HE-treated mice is concurrent with a direct effect of HE on RBCs that reduces their invasion by Plasmodium. It was also noticed that multiple infection preferentially occurred in strep -for both groups of mice ( Fig 5B) . Considering that sulfo NHS-biotin labelling does not affect infection of RBC by Plasmodium [35] , this observation rather suggests preference of P. c. adami for relatively younger but mature RBCs. In addition, the fact that hemopexin levels increased rapidly in both groups of P. c. adami-infected mice implies effective scavenging of free HE concurrent to hemolysis in this mouse infection model (S2 Fig) .
HE pre-treatment of RBCs reduces Plasmodium falciparum parasitemia and decreases the proportion of RBCs susceptible to parasite invasion
To further establish a link between decreased Plasmodium parasitemia and HE, an assay was performed with P. falciparum parasites cultured in control or HE-pretreated RBCs. To avoid HE-induced eryptosis in vitro, RBCs were kept in medium containing albumin, a protein known to inhibit~50% of HE-peroxidative activity [36] . Parasitemia was measured daily with Giemsa-stained smears and an SI was estimated at the time near to peak parasitemia (4 and 6 days post-in vitro infection). As with the P. c. adami infection in mice, P. falciparum parasitemia was significantly reduced from day 5 to 7 post-infection in HE-pretreated RBCs (Fig 6A) . The reduced parasitemia was accompanied by significant increase in the percentages of iRBCs with multiple rings, and a 3 fold increase in P. falciparum RBCs selectivity index (Fig 6B and  6E) . Thus, the observations with the mouse model were reproduced in the human infection model and suggest similar effects of HE on murine and human RBCs. 
Discussion
Severe hemolytic anemia in malaria is caused by the destruction of host RBCs following Plasmodium parasite growth and, to a greater extent, by the elimination of uninfected RBCs [10, 12, 37] . Free Hgb oxidises through ROS, resulting in methemoglobin formation and release of free unbound HE groups [16] . It has been reported that free HE exerts potent pro-oxidant, pro-apoptotic and pro-inflammatory properties, and that it controls a variety of biochemical processes involved in immune modulation [22, 23, [38] [39] [40] [41] [42] . Having previously reported that HE alters macrophages and T cells responses in a manner expected to be detrimental for the control of malaria [22, 23] , it was surprising to find a decrease in P. c. adami parasitemia in mice preconditioned with HE. Our results suggest that the protection provided by HE against the development of high parasitemia in mice is not due to an increased elimination of iRBCs, nor to impaired merozoite differentiation. The higher prevalence of free merozoites as well as the increased selectivity imposed on the parasites, with reduced invasion capability of HE [43] and are attained by more oxidative insults [44] [45] [46] , we speculate that older RBCs may be more sensitive to HE. This assumption may explain why P. berghei parasitemia is not affected in HE conditioned mice, as P. berghei parasites preferentially invade reticulocytes [47] . Rapid invasion of RBCs is fundamental for Plasmodium parasites, which are exposed to the host immune response during this transitory period, i.e., antibody opsonisation, cytotoxic, natural killer and γδ T cells killing, and macrophages and neutrophils phagocytosis [48, 49] . Time-lapse imaging analysis of invasion of RBC by P. falciparum and P. yoelii in vitro reveals an invasion capability in merozoites of only few seconds [50] , which implies that not only the host immune response forces the merozoites to haste themselves into RBCs, but that other environmental or intrinsic factors (found in vitro) may exert pressure towards a quick invasion process. Accordingly, delayed invasion of HE-conditioned RBCs by P. c. adami merozoites, instigated by a reduced availability of permissive host cells, could be a possible cause for the decreased parasitemia found in HE-preconditioned mice.
The invasion process represents a rapid succession of steps involving the association and reorganization of several parasite/RBC proteins [50, 51] , and any flaw of progression could result in reduced invasion by Plasmodium. Of the known impacts that HE may have on RBCs, the oxidative insults are potentially the most plausible causes for reduced infection [52] . The drop in parasitemia evidenced in P. falciparum cultures with HE-conditioned RBCs in vitro supports this idea. HE may cause peroxidation of membrane lipids and proteins [53] ,which are critical for merozoites invasion. Furthermore, HE induces conformational modifications of cytoskeletal proteins in RBCs [53, 54] that are essential for Plasmodium entrance [55, 56] . As the parasitophorous vacuole of Plasmodium is mostly composed of the host cell membrane lipids [57] , it is reasonable to assume that peroxidation of these lipids may interfere with vacuole formation and parasite invasion.
The increased P. c. adami and P. falciparum SI found in HE conditioned mice and HEtreated RBCs cultures raises another plausible explanation for the decreased parasitemia following HE treatment. The SI predicts the specificity of Plasmodium's merozoites for a particular population of RBCs. As the permissive population narrows, the chances for multiple merozoites invading a single RBC increase and a higher SI is expected. A SI of 2.5, as found for P. c. adami, indicates a nearly twofold increase in multiple iRBCs than predicted in a random distribution, and a mean SI of 1, as found in in vitro P. falciparum iRBCs, indicates a proportion of multiple iRBCs depictive of an unrestricted invasion process [26, 33, 34] . HE preconditioning increased these SI to 5.5 and 3.8, respectively for P. c. adami and P. falciparum infections, revealing additional two-and threefold higher chances that more than 1 merozoite infects a single RBC. The fate of such multiple iRBC is not known. It is acknowledge that the viability of the parasite may be hindered by nutritional and space limitations in face of multiple infections, and may represent a "dead end" for the parasite [58] . As mature schizonts enclosing higher numbers of merozoites were not evident in HE-pretreated infected mice, we may assume restricted individual development of the merozoites infecting a single RBC. Accordingly, the drop in parasitemia measured in HE-conditioned mice seems consequent to extraerythrocytic neutralization of merozoites that fail in rapidly invading the permissive RBCs, and in limitation of Plasmodium development in multiple iRBCs.
Although studies have reported HE pro-eryptotic properties in vitro in absence of scavenger proteins [17, 18] , our in vivo data suggest no impact of free HE on the viability of circulating RBCs and their turnover at the concentration tested, despite 60% drops in plasma hemopexin levels. Discrepancies between the in vitro and in vivo effects of HE may reflect the presence and recycling ability of hemopexin following its delivery of HE to hepatocytes, which supports the prevalence of unbound hemopexin and a persistent HE scavenging activity in vivo [59, 60] . The significant increase in plasma hemopexin found in P. c. adami infected mice suggests a difference in its induction pathway in mice and humans, since pronounced exhaustion of hemopexin occurs during human malaria [10] . In this respect, it is tempting to speculate that hemopexin depletion in the human host may further enhance the impact of HE on parasitemia, and thus may explain the disparity between severe malaria defined by parasitemias of % 20% in mice versus ! 0.5% in man [61, 62] .
One of the major outcomes in blood stage malaria is an exacerbated hemolytic anemia, which may be concurrent to various mechanisms [10, 12-14, 63, 64] . As a consequence, high plasma concentrations of free HE (% 20 μM) are reached in individuals with symptomatic malaria, and compromised hemopexin scavenging protection [21] . Similarly, many inherited blood disorders are characterized by chronic intravascular hemolysis of diverse aetiologies and heighten plasma concentrations of free HE. Interestingly, these disorders share a common protection against malaria morbidity and mortality [4] [5] [6] . According to the acknowledged Haldane's malaria hypothesis [8] , infectious diseases are a driving force in natural selection, and the long coexistence of humans and Plasmodium parasites has shaped the human genetic background in malaria endemic areas. In this respect, it is interesting to allege that severe malarial hemolytic anemia, as well as the protection provided by congenital hemolytic disorders, could in part arise from selective pressure tending towards the survival advantage of reduced lifethreatening parasite densities concurrent to the release of HE.
Supporting Information Plasmatic hemopexin levels were quantified by ELISA, 24 hours after the third saline/HE treatment, as well as throughout the infection. The results are the means ± SEM of two independent experiments (n = 3-6), and were compared with an unpaired (Ctrl/HE) and paired (Ctrl day 0/day 7; HE day 0/day4) Student t test, ÃÃ p<0.01, ÃÃÃ p<0.001.
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